Recall of EpiPen 300 - 20 March 2017
All EpiPens with an April 2017 expiry date are being recalled because of a possible defect that may result in difficulty activating the device in an emergency.
This recall is being conducted by Alphapharm in consultation with the Australian Therapeutic Goods Administration(TGA). Alphapharm Initiates Recall of EpiPen® Auto-Injector in Australia EpiPen® 300 microgram (μg) Adrenaline Injection Syringe Auto-InjectorBatches 5FA665, 5FA6651, 5FA6652, 5FA6653 Alphapharm Pty Ltd, following consultation with the Therapeutic Goods Administration, is recalling the following batches of EpiPen® 300 microgram (μg) Adrenaline Injection Syringe Auto-Injectors due to the potential that these devices may contain a defective part that may result in the device failing to activate or requiring increased force to activate. Batch number Expiry 5FA665 Apr 17 5FA6651 Apr 17 5FA6652 Apr 17 5FA6653 Apr 17